litlas
Log inCreate account

Carla J. Greenbaum

Active 1990–2025

127
Papers
20,015
Citations
80
h-index
124
i10-index

Citations

Citations per year for Carla J. Greenbaum1992: 2 citations1995: 3 citations1996: 1 citations1997: 1 citations1998: 3 citations1999: 6 citations2000: 4 citations2001: 7 citations2002: 13 citations2003: 20 citations2004: 12 citations2005: 29 citations2006: 25 citations2007: 42 citations2008: 70 citations2009: 57 citations2010: 85 citations2011: 91 citations2012: 111 citations2013: 172 citations2014: 150 citations2015: 203 citations2016: 150 citations2017: 173 citations2018: 236 citations2019: 624 citations2020: 715 citations2021: 888 citations2022: 683 citations2023: 717 citations2024: 1,121 citations2025: 634 citations2026: 12 citations1993–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,839 citing papers, 29.5% of this breakdownUnited Kingdom: 547 citing papers, 8.8% of this breakdownChina: 331 citing papers, 5.3% of this breakdownGermany: 320 citing papers, 5.1% of this breakdownCanada: 311 citing papers, 5% of this breakdownItaly: 304 citing papers, 4.9% of this breakdownAustralia: 240 citing papers, 3.9% of this breakdownSweden: 235 citing papers, 3.8% of this breakdownFrance: 194 citing papers, 3.1% of this breakdownNetherlands: 148 citing papers, 2.4% of this breakdownBelgium: 127 citing papers, 2% of this breakdownSpain: 122 citing papers, 2% of this breakdown
0%29.5%Other 24.2%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology48.3%
  • Medicine38%
  • Immunology and Microbiology10%
  • Dentistry0.9%
  • Neuroscience0.5%
  • Health Professions0.4%
  • Other1.9%

Topics

  • Diabetes and associated disorders18.7%
  • Pancreatic function and diabetes15.7%
  • Diabetes Management and Research12.6%
  • T-cell and B-cell Immunology5.1%
  • Immune Cell Function and Interaction4.7%
  • Cancer Genomics and Diagnostics1.8%
  • Other41.4%

Coauthors

All papers

Open in search
  1. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

    Authors: Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum - New England Journal of Medicine 2019 cited by 1,112

  2. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association

    Authors: Richard A. Insel, Jessica L. Dunne, Mark A. Atkinson, Jane L. Chiang, Dana Dabelea, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jeffrey P. Krischer, Åke Lernmark, Robert E. Ratner, Marian Rewers, Desmond Schatz, Jay S. Skyler, Jay M. Sosenko, Anette‐G. Ziegler - Diabetes Care 2015 cited by 1,148

  3. Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

    Authors: Emily K. Sims, Brian N. Bundy, Kenneth Stier, Elisavet Serti, Noha Lim, S. Alice Long, Susan Geyer, Antoinette Moran, Carla J. Greenbaum, Carmella Evans‐Molina, Kevan C. Herold, Type 1 Diabetes TrialNet Study Group, Linda A. DiMeglio, Stephen E. Gitelman, Peter A. Gottlieb, Jennifer B. Marks, Wayne D. Moore, Henry Rodriguez, William E. Russell, Desmond Schatz, Eva Tsalikian, Diane K. Wherrett, Anette‐Gabriele Ziegler - Science Translational Medicine 2021 cited by 359

  4. Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

    Authors: Emily K. Sims, Rachel Besser, Colin Dayan, Cristy Geno Rasmussen, Carla J. Greenbaum, Kurt Griffin, William Hagopian, Mikael Knip, Anna E. Long, Frank B. Martin, Chantal Mathieu, Marian Rewers, Andrea K. Steck, John M. Wentworth, Stephen S. Rich, Olga Kordonouri, Anette‐Gabriele Ziegler, Kevan C. Herold, for the NIDDK Type 1 Diabetes TrialNet Study Group - Diabetes 2022 cited by 230

  5. Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

    Authors: Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Paula McGee, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, John M. Lachin, Jay S. Skyler - New England Journal of Medicine 2009 cited by 1,073

  6. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

    Authors: Manuela Battaglia, Simi Ahmed, Mark S. Anderson, Mark A. Atkinson, Dorothy Becker, Polly J. Bingley, Emanuele Bosi, Todd M. Brusko, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Carla J. Greenbaum, Peter A. Gottlieb, Kevan C. Herold, Martin J. Hessner, Mikael Knip, Laura M. Jacobsen, Jeffrey P. Krischer, S. Alice Long, Markus Lundgren, Eoin McKinney, Noel G. Morgan, Richard A. Oram, Tomi Pastinen, Michael C. Peters, Alessandra Petrelli, Xiaoning Qian, María J. Redondo, Bart O. Roep, Desmond Schatz, David Skibinski, Mark Peakman - Diabetes Care 2019 cited by 344

  7. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    Authors: Tihamer Orban, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Philip Raskin, Henry Rodriguez, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler - The Lancet 2011 cited by 601

  8. Identification of tissue-specific cell death using methylation patterns of circulating DNA

    Authors: Roni Lehmann‐Werman, Daniel Neiman, Hai Zemmour, Joshua Moss, Judith Magenheim, Adi Vaknin‐Dembinsky, Sten Rubertsson, Bengt Nellgård, Kaj Blennow, Henrik Zetterberg, Kirsty L. Spalding, Michael J. Haller, Clive Wasserfall, Desmond Schatz, Carla J. Greenbaum, Craig Dorrell, Markus Grompe, Aviad Zick, Ayala Hubert, Myriam Maoz, Volker Fendrich, Detlef K. Bartsch, Talia Golan, Shmuel A. Ben Sasson, Gideon Zamir, Aharon Razin, Howard Cedar, A. M. James Shapiro, Benjamin Gläser, Ruth Shemer, Yuval Dor - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 621

  9. Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial

    Authors: Kevan C. Herold, Stephen E. Gitelman, Mario R. Ehlers, Peter A. Gottlieb, Carla J. Greenbaum, William Hagopian, Karen D. Boyle, Lynette Keyes-Elstein, Sudeepta Aggarwal, Deborah Phippard, Peter H. Sayre, James McNamara, Jeffrey A. Bluestone, and the AbATE Study Team - Diabetes 2013 cited by 405

  10. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial

    Authors: William E. Russell, Brian N. Bundy, Mark S. Anderson, Laura A. Cooney, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Michael J. Haller, Jeffrey P. Krischer, Ingrid Libman, Peter S. Linsley, S. Alice Long, Sandra Lord, Daniel J. Moore, Wayne V. Moore, Antoinette Moran, Andrew Muir, Philip Raskin, Jay S. Skyler, John M. Wentworth, Diane K. Wherrett, Darrell M. Wilson, Anette‐Gabriele Ziegler, Kevan C. Herold, Type 1 Diabetes TrialNet Study Group - Diabetes Care 2023 cited by 96

  11. Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

    Authors: Mark Rigby, Kristina M. Harris, Ashley Pinckney, Linda A. DiMeglio, Marc Rendell, Eric I. Felner, Jean M. Dostou, Stephen E. Gitelman, Kurt Griffin, Eva Tsalikian, Peter A. Gottlieb, Carla J. Greenbaum, Nicole Sherry, Wayne V. Moore, Roshanak Monzavi, Steven M. Willi, Philip Raskin, Lynette Keyes-Elstein, S. Alice Long, Sai Kanaparthi, Noha Lim, Deborah Phippard, Carol L. Soppe, Margret L. Fitzgibbon, James McNamara, Gerald T. Nepom, Mario R. Ehlers, the Immune Tolerance Network (ITN) T1DAL Study Group - Journal of Clinical Investigation 2015 cited by 292

  12. Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

    Authors: Michael J. Haller, Desmond Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Jessica Miller, Mark A. Atkinson, Dorothy J. Becker, David A. Baidal, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Jennifer B. Marks, Antoinette Moran, Henry Rodriguez, William E. Russell, Darrell M. Wilson, Carla J. Greenbaum, Type 1 Diabetes TrialNet ATG-GCSF Study Group, Carla J. Greenbaum, Mark A. Atkinson, David A. Baidal, M. Battaglia, Dorothy Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Mark A. Clements, Peter G. Colman, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Mikael Knip, J. Krischer, Åke Lernmark, W. Moore, Antoinette Moran, Andrew J. Muir, J. Palmer, Mark Peakman, Louis H. Philipson, Philip Raskin, María J. Redondo, Henry Rodriguez, W. J. Russell, Lisa M. Spain, Desmond Schatz, Jay M. Sosenko, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Mark S. Anderson, Peter A. Antinozzi, Christophe Benoıst, J.J. Blum, Kasia Bourcier, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, Catherine C. Cowie, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, L. Harrison, Bernhard J. Hering, Richard A. Insel, Sabine D. Jordan, Francine Kaufman, Tom Kay, Norma S. Kenyon, R. Klines, John M. Lachin, Ellen Leschek, Jeff Mahon, Jennifer B. Marks, Roshanak Monzavi, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, A. Pugliese, John A. Ridge, Bart O. Roep, Maria Grazia Roncarolo, Peter J. Savage, Olli Simell, R S Sherwin, Mark Siegelman, Jay S. Skyler, Andrea K. Steck, James W. Thomas, Massimo Trucco and 212 more - Diabetes Care 2018 cited by 180

  13. B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results

    Authors: Mark D. Pescovitz, Carla J. Greenbaum, Brian N. Bundy, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler, the Type 1 Diabetes TrialNet Anti-CD20 Study Group - Diabetes Care 2013 cited by 282

  14. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

    Authors: Antoinette Moran, Brian N. Bundy, Dorothy Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Carla J. Greenbaum, Kevan C. Herold, Jennifer B. Marks, Philip Raskin, Srinath Sanda, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler, Linda Pickersgill, Eelco J.P. de Koning, Anette‐G. Ziegler, Bernhard O. Boehm, Klaus Badenhoop, Nanette C. Schloot, J. F. Bak, Paolo Pozzilli, Dı́dac Mauricio, Marc Y. Donath, Luís Castaño, Ana M. Wägner, H. H. Lervang, Hans Perrild, Thomas Mandrup‐Poulsen - The Lancet 2013 cited by 354

  15. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

    Authors: María J. Redondo, Susan Geyer, Andrea K. Steck, Seth A. Sharp, John M. Wentworth, Michael N. Weedon, Peter A. Antinozzi, Jay M. Sosenko, Mark A. Atkinson, Alberto Pugliese, Richard A. Oram, Type 1 Diabetes TrialNet Study Group, Peter A. Antinozzi, Mark A. Atkinson, Manuela Battaglia, Dorothy J. Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Peter G. Colman, Peter A. Gottlieb, Kevan C. Herold, Richard A. Insel, Tom Kay, Mikael Knip, Jennifer B. Marks, Antoinette Moran, James L. Palmer, Mark Peakman, Louis H. Philipson, Alberto Pugliese, P. Raskin, Henry Rodriguez, Bart O. Roep, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Christophe Benoıst, J.J. Blum, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, Bernhard J. Hering, Francine Kaufman, Ellen Leschek, J. Mahon, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, Maria Grazia Roncarolo, Olli Simell, Robert Sherwin, Mark Siegelman, Andrea K. Steck, James W. Thomas, Massimo Trucco, J. Richard Wagner, Carla J. Greenbaum, Katarzyna Bourcier, Richard A. Insel, Jeffrey P. Krischer, Ellen Leschek, Lisa Rafkin, Lisa M. Spain, Catherine C. Cowie, Mary A. Foulkes, Heidi Krause‐Steinrauf, John M. Lachin, Saúl Malozowski, John Peyman, J P Ridge, Peter J. Savage, Jay S. Skyler, Stephanie J. Zafonte, Norma S. Kenyon, Irene Santiago, Jay M. Sosenko, Brian N. Bundy, Michael Abbondondolo, Timothy E. Adams, Darlene Amado, Ilma Asif, Matthew Boonstra, Brian N. Bundy, Cristina Burroughs, David Cuthbertson, Mary Deemer, Christopher Eberhard, Steve Fiske, Julie Ford, Jennifer Garmeson and 1,520 more - Diabetes Care 2018 cited by 169

  16. Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression

    Authors: Alice Wiedeman, Virginia Muir, Mario G. Rosasco, Hannah A. DeBerg, Scott Presnell, Bertrand Haas, Matthew J. Dufort, Cate Speake, Carla J. Greenbaum, Elisavet Serti, Gerald T. Nepom, Gabriele Blahnik, Anna Kus, Eddie A. James, Peter S. Linsley, S. Alice Long - Journal of Clinical Investigation 2019 cited by 161

  17. Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data

    Authors: Michael J. Haller, S. Alice Long, J. Lori Blanchfield, Desmond Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Susan Geyer, Megan Warnock, Jessica Miller, Mark A. Atkinson, Dorothy J. Becker, David A. Baidal, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Jennifer B. Marks, Antoinette Moran, Henry Rodriguez, William E. Russell, Darrell M. Wilson, Carla J. Greenbaum, Type 1 Diabetes TrialNet ATG-GCSF Study Group, Carla J. Greenbaum, Mark A. Atkinson, David A. Baidal, Manuela Battaglia, Dorothy J. Becker, P. J. Bingley, Emanuele Bosi, Jane H. Buckner, Mark A. Clements, Peter G. Colman, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Robin Goland, Peter Gottlieb, Kevan C. Herold, Mikael Knip, Jeffrey P. Krischer, Åke Lernmark, Wayne D. Moore, Antoinette Moran, Andrew J. Muir, Jerry P. Palmer, Mark Peakman, Louis H. Philipson, Philip Raskin, María J. Redondo, Henry Rodriguez, William E. Russell, Desmond A. Schatz, Jay M. Sosenko, Lisa M. Spain, John M. Wentworth, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette G. Ziegler, Mark S. Anderson, Peter A. Antinozzi, Richard A. Insel, Thomas W. H. Kay, Jennifer B. Marks, Alberto Pugliese, Bart O. Roep, Jay S. Skyler, Jorma Toppari, Carla J. Greenbaum, Jeffrey P. Krischer, Ellen Leschek, Lisa Spain, Katarzyna Bourcier, Richard A. Insel, J P Ridge, Jay S. Skyler, Carla J. Greenbaum, Lisa Rafkin, Jay M. Sosenko, Jay S. Skyler, Irene Santiago, Jeffrey P. Krischer, Brian N. Bundy, Michael Abbondondolo, Timothy E. Adams, Ilma Asif, Jenna Bjellquist, Matthew Boonstra, Cristina Burroughs, Mario Cleves, David Cuthbertson, Meagan DeSalvatore, Christopher Eberhard, Steve Fiske, Julie Ford, Jennifer Garmeson, Susan Geyer and 178 more - Diabetes 2019 cited by 131

  18. Fall in C-Peptide During First 2 Years From Diagnosis

    Authors: Carla J. Greenbaum, Craig A. Beam, David Boulware, Stephen E. Gitelman, Peter A. Gottlieb, Kevan C. Herold, John M. Lachin, Paula McGee, Jerry P. Palmer, Mark D. Pescovitz, Heidi Krause‐Steinrauf, Jay S. Skyler, Jay M. Sosenko, on behalf of the Type 1 Diabetes TrialNet Study Group - Diabetes 2012 cited by 320

  19. OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody–Positive Individuals

    Authors: Alyssa Ylescupidez, Cate Speake, Susan L. Pietropaolo, Darrell M. Wilson, Andrea K. Steck, Jennifer L. Sherr, Jason L. Gaglia, Christine Bender, Sandra Lord, Carla J. Greenbaum - The Journal of Clinical Endocrinology & Metabolism 2023 cited by 38

  20. Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

    Authors: Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O’Neill, Tadej Battelino, Kirstine J. Bell, Rachel Besser, Ezio Bonifacio, Helen M. Colhoun, Jennifer Couper, Maria E. Craig, Thomas Danne, Carine de Beaufort, Klemen Dovč, Kimberly A. Driscoll, Sanjoy Dutta, Osagie Ebekozien, Helena Elding Larsson, Daniel J. Feiten, Brigitte I. Frohnert, Robert A. Gabbay, Mary Gallagher, Carla J. Greenbaum, Kurt Griffin, William Hagopian, Michael J. Haller, Christel Hendrieckx, Emile Hendriks, Richard I. G. Holt, Lucille Hughes, Heba M. Ismail, Laura M. Jacobsen, Suzanne Bennett Johnson, Leslie E. Kolb, Olga Kordonouri, Karin Lange, Robert W. Lash, Åke Lernmark, Ingrid Libman, Markus Lundgren, David M. Maahs, M. Loredana Marcovecchio, Chantal Mathieu, Kellee M. Miller, Holly K. O’Donnell, Tal Oron, Shivajirao P. Patil, Rodica Pop‐Busui, Marian Rewers, Stephen S. Rich, Desmond Schatz, Rifka Schulman‐Rosenbaum, Kimber M. Simmons, Emily K. Sims, Jay S. Skyler, Laura Smith, Cate Speake, Andrea K. Steck, Nicholas Thomas, Ksenia N. Tonyushkina, Riitta Veijola, John M. Wentworth, Diane K. Wherrett, Jamie Wood, Anette‐Gabriele Ziegler, Linda A. DiMeglio - Diabetes Care 2024 cited by 68

  21. Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes

    Authors: Jeffrey P. Krischer, Desmond Schatz, Brian N. Bundy, Jay S. Skyler, Carla J. Greenbaum - JAMA 2017 cited by 203

  22. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry

    Authors: Mikaël Chetboun, Élodie Drumez, Cassandra Ballou, Mehdi Maanaoui, Elizabeth H. Payne, Franca B. Barton, Julie Kerr‐Conte, Marie‐Christine Vantyghem, Lorenzo Piemonti, Michael R. Rickels, Julien Labreuche, François Pattou, Rodolfo Alejandro, M Aull, Melena D. Bellin, Thierry Berney, D Borja-Cacho, Kenneth L. Brayman, Enrico Cagliero, Robert Caïazzo, Mark S. Cattral, Toby Coates, Kirstie K. Danielson, F. Defrance, E De Koning, Chintan Desai, Niraj M. Desai, A. Osama Gaber, Valéry Gmyr, Paul F. Gores, John A. Goss, P Gottllieb, Carla J. Greenbaum, Mark A. Hardy, David M. Harlan, Bernhard J. Hering, Fouad Kandeel, Dixon B. Kaufman, Thomas W. H. Kay, Bart Keymeulen, Khalid Khan, Yogish C. Kudva, Christian P. Larsen, Kristell Le Mapihan, G Levy, Marlon F. Levy, Thomas Loudovaris, Torbjörn Lundgren, Paola Maffi, James F. Markmann, W H Marks, Ali Naji, Philip J. O’Connell, José Oberholzer, Jon S. Odorico, Nicholas Onaca, François Pattou, Lorenzo Piemonti, Daniël Pipeleers, Andrew M. Posselt, Amer Rajab, Violeta Raverdy, Michael R. Rickels, Camillo Ricordi, A A Rossini, F Saudek, Beth Schrope, Antonio Secchi, Peter Senior, A. M. James Shapiro, James Shaw, Peter G. Stock, Diego Sánchez Thomas, Matthew Thompson, Marie‐Christine Vantyghem, L Vargas, H Wang, Anthony Wiseman, Piotr Witkowski, Kun‐Ho Yoon, Piotr Witkowski, Kun‐Ho Yoon - The Lancet Diabetes & Endocrinology 2023 cited by 61

  23. CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study

    Authors: Darrell M. Wilson, Susan L. Pietropaolo, Maria Acevedo-Calado, Shuai Huang, Oriehi Edisemi Destiny Anyaiwe, David Scheinker, Andrea K. Steck, Madhuri M. Vasudevan, Siripoom McKay, Jennifer L. Sherr, Kevan C. Herold, Jessica L. Dunne, Carla J. Greenbaum, Sandra Lord, Michael J. Haller, Desmond Schatz, Mark A. Atkinson, Patrick W. Nelson, Massimo Pietropaolo, the Type 1 Diabetes TrialNet Study Group - Diabetes Care 2023 cited by 51

  24. Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis

    Authors: the Immune Tolerance Network, Ana Luisa Perdigoto, Paula Preston‐Hurlburt, Pamela Clark, S. Alice Long, Peter S. Linsley, Kristina M. Harris, Steven Gitelman, Carla J. Greenbaum, Peter A. Gottlieb, William Hagopian, Alyssa Woodwyk, James Dziura, Kevan C. Herold - Diabetologia 2018 cited by 125